Request Demo
Last update 04 Jan 2026
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Last update 04 Jan 2026
Overview
Tags
Cardiovascular Diseases
Neoplasms
Respiratory Diseases
Recombinant protein
Biosimilar
Enzyme
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ChiCTR2300068482
A prospective, multicenter, double-blind, randomized controlled clinical study was conducted to evaluate the efficacy and safety of cross-linked sodium hyaluronate gel for injection in correcting moderate to severe nasolabial wrinkles in adult
CTR20212794
YS001胶囊治疗晚期恶性实体瘤患者的开放标签、多中心、剂量递增和扩展I期临床试验
[Translation] An open-label, multicenter, dose-escalation and expansion phase I clinical trial of YS001 capsules in patients with advanced malignant solid tumors
CTR20160855
重组人血管内皮抑素注射液在中国晚期实体瘤患者中单次及多次静脉滴注给药的耐受性及药代动力学研究
[Translation] Study on the tolerability and pharmacokinetics of single and multiple intravenous infusions of recombinant human endostatin injection in Chinese patients with advanced solid tumors
100 Clinical Results associated with Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 08 Jan 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
2
1
Phase 3
Approved
3
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free